CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 897 enrolled
Drug / intervention
Cataract Surgery +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01085357
NCT01085357N/ACompleted
CompareCT.gov

A Prospective, Randomized, Comparative, MultiCenter Clinical Study to Assess the Safety and Effectiveness of the Transcend CyPass Glaucoma Implant in Patients With Open Angle Glaucoma Undergoing Cataract Surgery

Transcend Medical, Inc.·interventional·Posted Mar 11, 2010·Updated May 15, 2017

In Brief

A clinical study evaluating Cataract Surgery and CyPass Micro-Stent for Primary Open Angle Glaucoma (POAG) and Cataract. Completed, enrolled 897 participants.

Detailed Summary

The purpose of this study is to evaluate the safety and efficacy of the CyPass Implant for lowering intraocular pressure (IOP) in patients with glaucoma who undergo cataract surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Open Angle Glaucoma (POAG), Cataract
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 11, 2010
Enrollment StartSep 1, 2009
Primary CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 16.3 years ago

Interventions

Cataract Surgeryprocedure

Cataract Surgery involves the removal of the natural lens, which has become clouded (called a cataract), and insertion of an artificial lens (called an intraocular lens). This procedure is done through a small surgical incision in the eye.

CyPass Micro-Stentdevice

The CyPass Micro-Stent is a small tube with a through-lumen designed to redirect aqueous fluid from the front to the back of the eye. The CyPass is implanted in the eye after completion of cataract surgery.